MARC details
000 -LEADER |
fixed length control field |
03584nam a22005175i 4500 |
003 - CONTROL NUMBER IDENTIFIER |
control field |
DE-He213 |
005 - DATE AND TIME OF LATEST TRANSACTION |
control field |
20231109085837.0 |
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION |
fixed length control field |
cr nn 008mamaa |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
fixed length control field |
220325s2022 sz | s |||| 0|eng d |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
International Standard Book Number |
9783030943837 |
024 7# - OTHER STANDARD IDENTIFIER |
Standard number or code |
10.1007/978-3-030-94383-7 |
Source of number or code |
doi |
040 ## - CATALOGING SOURCE |
Original cataloging agency |
TR-AnTOB |
Language of cataloging |
eng |
Transcribing agency |
TR-AnTOB |
Description conventions |
rda |
060 ## - NATIONAL LIBRARY OF MEDICINE CALL NUMBER |
Classification number |
WT 155 |
072 #7 - SUBJECT CATEGORY CODE |
Subject category code |
MJX |
Source |
bicssc |
|
Subject category code |
MED032000 |
Source |
bisacsh |
|
Subject category code |
MKN |
Source |
thema |
096 ## - LOCALLY ASSIGNED NLM-TYPE CALL NUMBER (OCLC) |
Classification number |
WT155EBK |
041 ## - LANGUAGE CODE |
Language code of text/sound track or separate title |
İngilizce |
245 10 - TITLE STATEMENT |
Title |
Pharmacological Treatment of Alzheimer's Disease |
Medium |
[electronic resource] : |
Remainder of title |
Scientific and Clinical Aspects / |
Statement of responsibility, etc. |
edited by Gustavo Alves Andrade dos Santos. |
250 ## - EDITION STATEMENT |
Edition statement |
1st ed. 2022. |
264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE |
Place of production, publication, distribution, manufacture |
Cham : |
Name of producer, publisher, distributor, manufacturer |
Springer International Publishing : |
-- |
Imprint: Springer, |
Date of production, publication, distribution, manufacture, or copyright notice |
2022. |
300 ## - PHYSICAL DESCRIPTION |
Extent |
1 online resource |
336 ## - CONTENT TYPE |
Content type term |
text |
Content type code |
txt |
Source |
rdacontent |
337 ## - MEDIA TYPE |
Media type term |
computer |
Media type code |
c |
Source |
rdamedia |
338 ## - CARRIER TYPE |
Carrier type term |
online resource |
Carrier type code |
cr |
Source |
rdacarrier |
347 ## - DIGITAL FILE CHARACTERISTICS |
File type |
text file |
Encoding format |
PDF |
Source |
rda |
505 0# - FORMATTED CONTENTS NOTE |
Formatted contents note |
1. Introduction -- 2. Principles of Pharmacology in Dementia -- 3. The Viability of Treatment Conditioned to the Pathophysiology of Alzheimer's Disease -- 4. The Use of Esterase Inhibitors -- 5. Pharmacology of NMDA (N-methyl-D-aspartate) receptor antagonists in Alzheimer’s Disease -- 6. Supportive Pharmacological Treatment -- 7. Herbal Medicines and Supplements -- 8. Emergency Situations -- 9. Relationships between Treatment and Clinical Evaluations -- 10. New Perspectives for Treatment in Alzheimer's Disease. |
520 ## - SUMMARY, ETC. |
Summary, etc. |
Alzheimer’s disease is the most prevalent form of dementia. Although it was discovered about a century ago, the first drugs applied in treatment were only introduced in therapy in the last 30 years. This book focuses on the clinical pharmacology of drugs that aim to delay the progression of Alzheimer’s disease, such as anticholinesterases and glutamate receptor antagonists, as well as treatment for the behavioral changes caused by the progression of the disease: antidepressants, antipsychotics, anxiolytics, and mood stabilizers. In addition, it describes important information about the pathophysiology and diagnostic methods of Alzheimer’s disease, emergency situations conditioned by the dementia process, and presents new perspectives for the treatment of Alzheimer’s disease. The ten chapters cover topics such as mechanism of action, dosage regimen, adverse reactions, drug interactions, toxicity profiles, among other information of clinical relevance. The work comprises evidence-based studies, providing a valuable resource for analyzing, prescribing and monitoring patients being treated for Alzheimer’s disease. Written by experts with solid professional experience, this book will appeal to pharmacologists, geriatricians, neurologists, psychiatrists, biomedical clinicians, and other healthcare professionals. |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Geriatrics. |
|
Topical term or geographic name entry element |
Pharmacology. |
|
Topical term or geographic name entry element |
Psychiatry. |
|
Topical term or geographic name entry element |
Geriatrics. |
|
Topical term or geographic name entry element |
Pharmacology. |
|
Topical term or geographic name entry element |
Psychiatry. |
653 #0 - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
Alzheimer Disease -- drug therapy |
|
Uncontrolled term |
Alzheimer Disease -- genetics |
|
Uncontrolled term |
Cognition -- physiology |
700 1# - ADDED ENTRY--PERSONAL NAME |
Personal name |
Santos, Gustavo Alves Andrade dos. |
Relator term |
editor. |
Relator code |
edt |
-- |
http://id.loc.gov/vocabulary/relators/edt |
710 2# - ADDED ENTRY--CORPORATE NAME |
Corporate name or jurisdiction name as entry element |
SpringerLink (Online service) |
856 40 - ELECTRONIC LOCATION AND ACCESS |
Uniform Resource Identifier |
<a href="https://doi.org/10.1007/978-3-030-94383-7">https://doi.org/10.1007/978-3-030-94383-7</a> |
Materials specified |
Springer eBooks |
Public note |
Online access link to the resource |
942 ## - ADDED ENTRY ELEMENTS (KOHA) |
Source of classification or shelving scheme |
National Library of Medicine |
Koha item type |
E-Book |